CDK4/6 Inhibitor Resistant Breast Cancer Models
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including:
- In vitro induced Palbociclib resistant MCF-7 cell line
- In vivo induced Palbociclib resistant MCF-7 model
- In vivo induced Abemaciclib resistant MCF-7 model
- In vivo induced Ribociclib resistant MCF-7 model
View additional drug-resistant models in our platform
WuXi AppTec CDK4_6 inhibitor resistant models-Newsletter
Related Content
Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are globally prevalent human pathogens associated with a wide range of...
VIEW RESOURCEAsthma is a chronic, lower airway disease characterized by persistent inflammation and hyperreactivity. Asthma involves a complex immune response, with...
VIEW RESOURCE